News

Novavax on Thursday tried to calm investors spooked by the delay of full approval of its COVID vaccine shot by U.S.
Vaccine maker Novavax is seeking to convert the 2022 emergency authorization of its Covid-19 vaccine into full approval. Yet ...
A federal district judge is allowing the CIA to fire the agency’s director of the Center for Global Health Services ...
Moderna’s combined Covid and flu shot outperformed the existing standalone vaccines for both viruses, according to the ...
Questions are answered by experts at the Oregon Health Authority, other state agencies or community partners. Questions and ...
Dr. Marty Makary, chief of the FDA, has expressed doubts about the agency approving the COVID-19 vaccine for winter, stating ...
A new vaccine developed by Moderna aims to protect against both flu and COVID-19 with just one shot. Early studies suggest ...
The plans amount to an extraordinary flex of Robert F. Kennedy Jr.’s power as health secretary to make decisions ordinarily ...
Momentum is building to scale back the current recommendation that all children over 6 months old get immunized against the ...
In recent interviews, Health and Human Services Secretary Robert F. Kennedy Jr. has minimized the risk COVID-19 poses to kids ...
There’s new uncertainty about updated COVID-19 shots this fall after the Trump administration’s handling of a shot from ...
Colleges that require students to undergo a COVID-19 vaccine will have their federal funding ended if House lawmakers get ...